• 1
    Beech J, Garcia M. Hormonal response to thyrotropin-releasing hormone in healthy horses and in horses with pituitary adenoma. Am J Vet Res 1985;46:19411943.
  • 2
    Thompson JC, Ellison R, Gillert R. Problems in the diagnosis of pituitary adenoma (Cushing's syndrome) in horses. NZ Vet J 1995;43:7982.
  • 3
    Hillyer MH, Taylor FGR, Mair TS, et al. Diagnosis of hyperadrenocorticism in the horse. Equine Vet Educ 1992;4:131134.
  • 4
    Eiler H, Oliver JW, Andrews FM, et al. Results of a combined dexamethasone suppression/thyrotropin-releasing hormone stimulation test in healthy horses and horses suspected to have a pars intermedia pituitary adenoma. J Am Vet Med Assoc 1997;211:7981.
  • 5
    Frank N, Andrews FM, Sommardahl CS, et al. Evaluation of the combined dexamethasone suppression/thyrotropin-releasing hormone stimulation test for detection of pars intermedia pituitary adenomas in horses. J Vet Intern Med 2006;20:987993.
  • 6
    Beech J, Boston R, Lindborg S, et al. Adrenocorticotropin concentration following administration of thyrotropin releasing hormone in healthy horses and those with pituitary pars intermedia dysfunction and pituitary hyperplasia. J Am Vet Med Assoc 2007;231:417425.
  • 7
    McFarlane D, Beech J, Cribb A. Alpha-melanocyte stimulating hormone release in response to thyrotopin releasing hormone in healthy horses, horses with pituitary pars intermedia dysfunction and equine pars intermedia explants. Domest Anim Endocrinol 2006;30:276288.
  • 8
    Singh AK, Jiang Y, White T, et al. Validation of nonradioactive chemiluminescent immunoassay methods for the analysis of thyroxine and cortisol blood samples obtained from dogs, cats, and horses. J Vet Diagn Invest 1997;9:261268.
  • 9
    Perkins GA, Lamb S, Erb HN, et al. Plasma adrenocorticotropin (ACTH) concentrations and clinical response in horses treated for equine Cushing's disease with cyproheptadine or pergolide. Equine Vet J 2002;34:679885.
  • 10
    Hosmer DW, Lemeshow S. Applied Logistic Regression, 2nd ed. Chapters 4 and 5. New York: Wiley; 2000.
  • 11
    Altman DG. Practical Statistics for Medical Research, 1st ed. Chapter 7. New York: Chapman and Hall; 1995.
  • 12
    Campbell MJ. Statistics at Square Two, 2nd ed. Chapters 2 and 3. London: BMJ Books, Blackwell Publ; 2006.
  • 13
    Collett D. Modelling Binary Data. 1st ed. Chapters 5 and 6. New York: Chapman and Hall; 1996.
  • 14
    Newson R. Confidence intervals for rank statistics: percentile slopes, differences, and ratios. Stata J 2006;6:497520.
  • 15
    Schott H. Pituitary pars intermedia dysfunction equine Cushing's disease. Vet Clin Equine 2002;18:237270.
  • 16
    McFarlane D, Cribb A. Alpha melanocyte stimulating hormone release in response to thyrotropin releasing hormone administration in healthy horses. J Vet Intern Med 2004;18:413.
  • 17
    Fazio E, Medica P, Ferlazzo A. Seasonal patterns of circulating β endorphin, adrenocorticotrophic hormone and cortisol levels in pregnant and barren mares. Bulg J Vet Med 2009;12:125135.
  • 18
    Schreiber CM, Stewart AJ, Behrend EN, et al. Seasonal variation in diagnostic tests for pituitary pars intermedia dysfunction in normal aged geldings. J Am Vet Med Assoc 2011; in press.
  • 19
    Place NJ, McGowan CM, Lamb SV, et al. Seasonal variation in serum concentrations of selected metabolic hormones in horses. J Vet Intern Med 2010;24:650654.
  • 20
    Donaldson MT, McDonnell SM, Schanbacher BJ, et al. Variation in plasma adrenocorticotrophic hormone concentration and dexamethasone suppression test results with season, age and sex in healthy ponies and horses. J Vet Intern Med 2005;19:217222.
  • 21
    Haritou SJA, Zylstra R, Ralli C, et al. Seasonal changes in circadian peripheral plasma concentrations of melatonin serotonin, dopamine and cortisol in aged horses with Cushing's disease under natural photoperiod. J Neuroendocrinol 2008;20:988996.
  • 22
    Sojka JE, Jackson PE, Moore GE, et al. Effect of season and dose on domperidone stimulated change in adrenocorticotrophic hormone concentrations in horses with pituitary pars intermedia dysfunction. Cambridge, MA: Dorothy Russell Havemeyer Foundation, Equine Geriatric Workshop; October 2010: p.41.
  • 23
    Funk RA, Stewart AJ, Woodridge AA, et al. Seasonal changes in plasma adrenocorticotrophic hormone and alpha-melanocyte stimulating hormone in response to thyrotropin releasing hormone in normal aged horses. J Vet Intern Med 2011;25:579585.
  • 24
    van der Kolk JH, Heinrichs M, Amerongen JD, et al. Evaluation of pituitary gland anatomy and histopathologic findings in clinically normal horses and horses and ponies with pituitary pars intermedia adenoma. Am J Vet Res 2004;65:17011707.
  • 25
    Alam MGS, Dobson H, Fitzpatrick RJ. Endocrine response to different doses of ACTH in cows. Br Vet J 1986;142:239245.
  • 26
    Bousquet-Melou A, Formentini E, Picard-Hagan N, et al. The adrenocorticotropin stimulation test: contributions of a physiologically based model developed in horse for its interpretation in different pathophysiological situations encountered in man. Endocrinology 2006;147:42814291.
  • 27
    Azziz R, Bradley E, Huth J, et al. Acute adrenocorticotropin (1-24) (ACTH) adrenal stimulation in eumonorrheic women: reproducibility and effect of ACTH dose, subject weight and sampling time. J Clin Endocrinol Metab 1990;70:12731279.
  • 28
    Krishnan KRR, Ritchie JC, Saunders W, et al. Nocturnal and early morning secretion of ACTH and cortisol in humans. Biol Psychiatry 1990;28:4757.
  • 29
    Fazio E, Medica P, Aronica V, et al. Circulating β-endorphin, adrenocorticotropic hormone and cortisol levels of stallions before and after short road transport: stress effect of different distances. Acta Vet Scand 2008;50:6.
  • 30
    Alexander SL, Irvine CHG. The effect of social stress on adrenal axis activity in horses: the importance of monitoring corticosteroid-binding globulin capacity. J Endocrinol 1998;157:425432.
  • 31
    Roelfsema F, Kok P, Frolich M, et al. Disordered and increased adrenocorticotropin secretion with diminished adrenocorticotropin potency in obese premenopausal women. J Clin Endocrinol Metab 2009;94:29912997.
  • 32
    Keenan DM, Roelfsema F, Carroll BJ, et al. Sex defines the age dependence of endogenous ACTH-cortisol dose responsiveness. Am J Physiol Regul Integr Comp Physiol 2009;297:R515R523.
  • 33
    Žarković M, Ignjatović S, Dajak M, et al. Cortisol response to ACTH stimulation correlates with blood interleukin 6 concentration in healthy humans. Eur J Endocrinol 2008;159:649652.
  • 34
    Pessina P, Fernández-Foren A, Cueto E, et al. Cortisol secretion after adrenocorticotropin (ACTH) and dexamethasone tests in healthy female and male dogs. Acta Vet Scand 2009;51:33.
  • 35
    Garnier F, Benoit E, Virat M, et al. Adrenal cortical response in clinically normal dogs before and after adaptation to housing. Lab Anim 1990;24:4043.
  • 36
    Cartmill JA, Thompson DL, Storer WA, et al. Endocrine responses in mares and geldings with high body condition scores grouped by high vs low resting leptin concentrations. J Anim Sci 2003;81:23112321.
  • 37
    van der Kolk JH, Wensing T, Kalsbeek HC, et al. Laboratory diagnosis of equine pituitary pars in intermedia adenoma. Domest Anim Endocrinol 1995;12:3539.
  • 38
    Goverde HJM, Pesman GJ, Smals AGH. The bioactivity of immunoreactive adrenocorticotrophin in human blood is dependent on the secretory state of the pituitary gland. Clin Endocrinol (Oxf) 1989;31:255265.
  • 39
    Poland RE, Hanada K, Rubin RT. Relationship of nocturnal plasma bioactive and immunoactive ACTH concentrations to cortisol secretion in normal men. Acta Endocrinol 1989;121:857865.
  • 40
    Krieger DT, Allen W. Relationship of bioassayable and immunoassayable plasma ACTH and cortisol concentrations in normal subjects and in patients with Cushing's disease. J Clin Endocrinol Metab 1975;40:675687.
  • 41
    Engeland WC, Miller P, Gann DS. Dissociation between changes in plasma bioactive and immunoreactive adreno-corticotrophin after hemorrhage in awake dogs. Endocrinology 1989;124:29782985.
  • 42
    Dempsher DP, Gann DS. Increased cortisol secretion after small hemorrhage is not attributable to changes in adrenocorticotropin. Endocrinology 1983;113:8693.
  • 43
    Castro MI, Valego NK, Zehnder TJ, et al. Bioactive-to-immunoreactive ACTH activity changes with severity of stress in late gestation ovine fetus. Am J Physiol 1993;265:E68E73.
  • 44
    Goverde HJM, Martens GJM, Pesman GJ, et al. Multiple forms of bioactive and immunoreactive adreno-corticotrophin in human pituitary and blood of patients with Nelson's syndrome. J Clin Endocrinol Metab 1993;77:443447.
  • 45
    Orth DN, Holscher MA, Wilson MG, et al. Equine Cushing's disease: Plasma immunoreactive proopiolipomelanocortin peptide and cortisol levels basally and in response to diagnostic tests. Endocrinology 1982;110:1430.
  • 46
    Orth DN, Nicholson WE. Bioactive and immunoreactive adrenocorticotropin in normal equine pituitary and in pituitary tumors of horses with Cushing's disease. Endocrinology 1982;111:559563.
  • 47
    Sommer K. Das Equine Cushing-Sydrom: Entwicklung cines ACTH-bioassays fur die Ermittlung des biologisch-immunreaktiven Verkaltnisses von endogenem ACTH in equinen Blutproben (The equine Cushing syndrome development of an ACTH-bioassay for determination of the biological-immunoreactive-ratio of endogenous ACTH in equine blood samples). Stiftung Tierarztliche Hockschule Hannover Dissertation. Hannover, Germany: School of Veterinary Medicine, 2003.
  • 48
    Shrauner B, Corder M, McFarlane D. Bioactivity of plasma ACTH in PPID-affected horses compared to normal horses. Cambridge, MA: Dorothy Russell Havemeyer Foundation, Equine Geriatric Workshop, October 2010; 53.